Orthostatic hypotension was not associated with increased mortality risk in 80-year-old individuals, whereas intensive hypertension treatment (>2 drugs) was associated with longer survival.
Cohort (n=224)
No
Does orthostatic hypotension or intensive antihypertensive treatment affect total and cardiovascular mortality in very elderly community-dwelling individuals?
In very elderly community-dwelling patients, orthostatic hypotension is common but not associated with increased mortality, whereas intensive antihypertensive treatment is associated with longer survival.
OBJECTIVE: The aim of this study was to examine the relationship between orthostatic hypotension, cardiovascular drug intake and mortality in a very elderly community-dwelling population (>80 years of age). METHODS: In 2013-2014, 224 (71 M, 31.7%) 80-year-old individuals from one primary care practice were invited to participate. Basic clinical information was gathered and blood pressure (BP) measurements were performed while sitting and after 1 and 3 min in the standing position on 209 patients. The individuals were followed till December 2016. RESULTS: Orthostatic hypotension was present, depending on applied definition, in 34.5% of the individuals at 1 min, 38.3% at 3 min; 44.9% on either 1 or 3 min, and 27.8% individuals in both measurements. Sixty-nine (30.8%) individuals died during the follow-up. Presence of orthostatic hypotension, irrespective of definition, did not have any significant association with the mortality risk in all groups. Intensive hypertension treatment (more than two drugs versus none) was associated with longer survival. In a multivariate logistic regression analysis, only age and presence of coronary heart disease/congestive heart failure had a negative predictive value on mortality. In both treated and untreated individuals, presence of orthostatic hypotension was not linked to mortality. CONCLUSION: Although orthostatic hypotension is very common among the very elderly, its presence is not related to increased risk of death (all-cause/cardiovascular). Intensively treated elderly patients had significantly longer survival time than untreated individuals.
Szyndler 외 (수요일,)은 기립성 저혈압 및 고혈압에 관한 코호트를 실시하였다 (n=224). 기립성 저혈압 및 집중적인 항고혈압 치료(>2 약물) 대 기립성 저혈압 없음 및 덜 집중적인 치료를 평가하여 총 및 심혈관 사망률에 미친 영향을 평가하였다. 80세 개인에서 기립성 저혈압은 사망 위험 증가와 연관이 없었으나, 집중적인 고혈압 치료(>2 약물)은 더 긴 생존과 연관이 있었다.